Questcor Pharmaceuticals Earnings Preview: Can This Streak Continue?
Questcor Pharmaceuticals (NASDAQ:QCOR) will report earnings after markets close on Tuesday, April 30th. Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company’s primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
Here is your Cheat Sheet to Questcor Pharmaceuticals Earnings:
Earnings Expectations: Analysts expect earnings of $0.96 per share on revenues of $157.16 million. Currently, the company’s P/E ratio stands at 9.24.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.97 to a profit $1.05. For the current year, the average estimate is a profit of $4.19, which is better than the estimate ninety days ago.
Here’s how Questcor Pharmaceuticals has been performing on an annual basis:
|Revenue ($) in millions||95.25||88.32||115.13||218.17||509.29|
|Diluted EPS ($)||0.49||0.40||0.54||1.21||3.14|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||75.54||95.97||112.45||140.34||160.53|
|Diluted EPS ($)||0.4724||0.58||0.65||0.91||1.025|
Questcor Pharmaceuticals has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)